Pfizer's Profit Outlook Rises Amidst Strong Q2 Performance
Pfizer boosts its 2025 profit forecast due to ongoing cost reductions and strong second-quarter sales driven by top-performing drugs.
This post is for paying subscribers only
Already have an account? Sign in.